国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
INTERNATIONAL JOURNAL OF ANESTHESIOLOGY AND RESUSCITATION
2014年
5期
401-404
,共4页
曾思%温开兰%蔡兵%陈亮%吕强%吕学文%兰志勋
曾思%溫開蘭%蔡兵%陳亮%呂彊%呂學文%蘭誌勛
증사%온개란%채병%진량%려강%려학문%란지훈
右美托咪定%利多卡因%罗库溴铵%注射痛
右美託咪定%利多卡因%囉庫溴銨%註射痛
우미탁미정%리다잡인%라고추안%주사통
Dexmedetomidine%Lidocaine%Rocuronium%Injection pain
目的 研究预先静脉注射右美托咪定(dexmedetomidine,Dex)和利多卡因对罗库溴铵注射痛的影响. 方法 选择行经口插管全麻的择期手术患者160例,美国麻醉医师协会(ASA)分级Ⅰ~Ⅱ级,按照随机数字表法分为4组:对照组(C组)、Dex低剂量组(D1组)、Dex高剂量组(D2组)和利多卡因组(L组),每组40例.D1组和D2组患者分别预先静脉泵注Dex0.2、0.4 μg/kg;L组患者预先静脉泵注利多卡因0.5 mg/kg;C组则给予等容生理盐水(10ml),均在10 min注射完毕.然后各组患者静脉注射罗库溴铵10 mg(1 ml),2s内推注完.立即评测患者疼痛评分、镇静评分,记录低血压、心动过缓及输注并发症. 结果 4组患者一般情况差异无统计学意义;C组注射痛发生率(82.5%)明显较D1组(60.0%)、D2组(40.0%)和L组(32.5%)高(P<0.05);D1组注射痛发生率明显高于D2组和L组(P<0.05);而D2组和L组注射痛发生率及疼痛程度相似;D2组镇静评分明显高于其他3组(P<0.05);各组低血压、心动过缓及输注并发症差异无统计学意义. 结论 预先静脉注射Dex 0.2、0.4μg/kg及利多卡因0.5 μg/kg均能明显减少罗库溴铵引起注射痛的发生率,且以Dex 0.4 μg/kg及利多卡因0.5 mg/kg效果最佳.
目的 研究預先靜脈註射右美託咪定(dexmedetomidine,Dex)和利多卡因對囉庫溴銨註射痛的影響. 方法 選擇行經口插管全痳的擇期手術患者160例,美國痳醉醫師協會(ASA)分級Ⅰ~Ⅱ級,按照隨機數字錶法分為4組:對照組(C組)、Dex低劑量組(D1組)、Dex高劑量組(D2組)和利多卡因組(L組),每組40例.D1組和D2組患者分彆預先靜脈泵註Dex0.2、0.4 μg/kg;L組患者預先靜脈泵註利多卡因0.5 mg/kg;C組則給予等容生理鹽水(10ml),均在10 min註射完畢.然後各組患者靜脈註射囉庫溴銨10 mg(1 ml),2s內推註完.立即評測患者疼痛評分、鎮靜評分,記錄低血壓、心動過緩及輸註併髮癥. 結果 4組患者一般情況差異無統計學意義;C組註射痛髮生率(82.5%)明顯較D1組(60.0%)、D2組(40.0%)和L組(32.5%)高(P<0.05);D1組註射痛髮生率明顯高于D2組和L組(P<0.05);而D2組和L組註射痛髮生率及疼痛程度相似;D2組鎮靜評分明顯高于其他3組(P<0.05);各組低血壓、心動過緩及輸註併髮癥差異無統計學意義. 結論 預先靜脈註射Dex 0.2、0.4μg/kg及利多卡因0.5 μg/kg均能明顯減少囉庫溴銨引起註射痛的髮生率,且以Dex 0.4 μg/kg及利多卡因0.5 mg/kg效果最佳.
목적 연구예선정맥주사우미탁미정(dexmedetomidine,Dex)화리다잡인대라고추안주사통적영향. 방법 선택행경구삽관전마적택기수술환자160례,미국마취의사협회(ASA)분급Ⅰ~Ⅱ급,안조수궤수자표법분위4조:대조조(C조)、Dex저제량조(D1조)、Dex고제량조(D2조)화리다잡인조(L조),매조40례.D1조화D2조환자분별예선정맥빙주Dex0.2、0.4 μg/kg;L조환자예선정맥빙주리다잡인0.5 mg/kg;C조칙급여등용생리염수(10ml),균재10 min주사완필.연후각조환자정맥주사라고추안10 mg(1 ml),2s내추주완.립즉평측환자동통평분、진정평분,기록저혈압、심동과완급수주병발증. 결과 4조환자일반정황차이무통계학의의;C조주사통발생솔(82.5%)명현교D1조(60.0%)、D2조(40.0%)화L조(32.5%)고(P<0.05);D1조주사통발생솔명현고우D2조화L조(P<0.05);이D2조화L조주사통발생솔급동통정도상사;D2조진정평분명현고우기타3조(P<0.05);각조저혈압、심동과완급수주병발증차이무통계학의의. 결론 예선정맥주사Dex 0.2、0.4μg/kg급리다잡인0.5 μg/kg균능명현감소라고추안인기주사통적발생솔,차이Dex 0.4 μg/kg급리다잡인0.5 mg/kg효과최가.
Objective To compare the efficacy of pretreatment with dexmedetomidine (Dex) and lidocaine to prevent rocuronium injection pain.Methods One hundred and sixty patients (ASA Ⅰ-Ⅱ) scheduled for elective surgery were randomly divided into 4 groups(n=40):control group(Group C),Dex 0.2 μg/kg group(Group D1),Dex 0.4 μg/kg group(Group D2) and lidocaine 0.5 mg/kg group (Group L).Patients in Group D1,Group D2 and Group L received intravenous Dex 0.2,0.4 μg/kg and lidocaine 0.5 mg/kg respectively,while patients in Group C received intravenous normal saline with the same volume(10 ml) within 10 min.Then all patients are intravenously injected rocuronium 10 mg (1 ml) within 2 s.The pain score,sedation and side effects were recorded.Results Demographic parameters were similar among groups.Comparing to Group C,the incidence of pain in Group C (82.5%) was significantly higher than that in Group D1 (60.0%),Group D2 (40.0%) and Group L(32.5%)(P<0.05).The frequency and intensity of rocuronium injection pain were statistically similar between Group D2 and Group L.The frequency of pain in the Group D2 and Group L was significantly less than the Group D1 (P<0.05).Sendation score in the Group D2 was significantly higher than the other three groups (P<0.05).Hypotension,bradycardia and side effects of injection were similar among groups.Conclusions Pretreatment with Dex and lidocaine was effective in reducing the frequency and severity of pain with rocuronium injection but pretreatment with Dex 0.4 μg/kg and lidocaine 0.5 mg/kg proved to be the most effective treatments.